Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs BIIB✓SelectedUSD · BIIBGSK vs BIIB performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs BIIB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.3%
BIIB return
+13.5%
Excess return
+51.8%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioBIIBExcessAlpha
1D+0.5%+1.2%-0.6%+0.2%
7D+1.1%+2.0%-0.9%+0.5%
30D+6.3%+8.8%-2.5%+3.8%
3M+1.8%+20.3%-18.5%-3.4%
6M+1.7%+23.9%-22.2%-4.7%
YTD+6.5%+44.0%-37.4%-4.9%
1Y+9.5%+53.8%-44.3%-4.2%
3Y+65.3%+13.8%+51.5%+43.6%
All+65.3%+13.5%+51.8%+43.6%

Cumulative growth

Daily Returns

Daily percentage return beside BIIB.

Daily Out/Under-Performance

Portfolio return minus BIIB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × BIIB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded BIIB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling